|
4.36 Gail Borden Building
Route: 0652
Telephone: (409) 742-3668
Fax: (409) 742-8028
E-mail:jperezpo@utmb.edu
B.S. 1965 Cornell University
M.S. 1965 Cornell University
Ph.D. 1970 Stanford University
Our long-term goals are to understand the mechanisms
of neuronal cell death and deficits associated with both acute and chronic
trauma to the central nervous system at a molecular and cellular level.
We have developed modified liposomal gene transfer and gene specific “decoy” inhibition
of transcription factor binding to promoter sites as intervention approaches
to therapy.
Our hypothesis is that oxidative stress in the nervous system, caused by
chronic or acute trauma, triggers inflammatory responses that result in the
uncoupling of gene networks responsible for cell viability and function that
result in the altered phenotypes associated with neural deficits present
injury, aging and Alzheimer’s Disease.
For example, inflammatory cascades activated by trauma have genotoxic and
energetic consequences that activate stress response genes via the NF-B transcription
factor. Transcription factors bind to cognate DNA sequences that regulate
stress response gene expression essential to survival and function. We believe
that transcription factor binding to cognate DNA sequences is finely tuned
by the specificity of the sequence, position within a promoter and protein-protein
interactions with other sites on a promoter. Our initial studies have focused
on: APE/Ref-1 DNA repair enzyme, the ß-amyloid generating BACE enzyme,
Bcl-protein family of genes, choline acetyltransferase, COX-2, DNA repair
processes, the IL-1 cytokine, and iNOS.
Working animal models include perinatal ischemia and spinal cord injury
in the rat as well as in vitro models. In vitro models used are the PC12
line and primary cultures derived from fetal and neonatal brain. We also
rely on transgenic models of Alzheimer’s Disease and focal stroke in
the aged rat.
We use in vivo MRI techniques to assess damage and vascular changes in brain
and spinal cord. In vitro reporter constructs and transgenic models suitable
to unraveling the role of the NF-kB transcription factor in transcriptional
regulation of select genes are also used. In addition, we are applying genomic,
proteomic and bioinformatics approaches to analyses of time course studies
of post-traumatic injury response and human clinical studies on the response
to treatment in burned children and animals models of neural trauma.
Studies are supported in part by the NINDS, NICHD, Shriners and Clayton
Foundations, and the Mission Connect Consortium and Sealy Program. Collaborative
efforts include the Oregon Health Science Center, Baylor College of Medicine,
University of Texas Houston Medical School, University of Leipzig, Germany.
- Toliver-Kinsky, T., T. Wood & J.R. Perez-Polo. Nuclear
Factor kappa B/p49 is a negative regulatory factor in nerve growth
factor-induced choline acetyltransferase Promoter activity in PC12
cells. J. Neurochemistry, 75:2241-2251,2000.
- Qiu, J-X., M.R. Grafe , S.M. Schmura., J. Glasgow, T.A.
Kent, D.K. Rassin, J.R. Perez-Polo. Differential NF-kB regulation of
bcl-x gene expression in Hippocampus and basal forebrain in response
to hypoxia. J. Neurosci. Res., 64:223-234, 2001.
- Nesic O., G-Y Xu, D. McAdoo, K. Westlund, C. Hulsebosch & J.R.
Perez-Polo. IL-1 receptor antagonist prevents apoptosis of spinal cord
cells after injury by decreasing caspase-3 activity. J. Neurotrauma,
18:947-956,2001.
- Nesic O., N. Svrakic, G-Y. Xu, D. McAdoo, K. N. Westlund,
C. E. Hulsebosch, Zeiming Ye, A. Galante, P. Soteropoulos, P. Tolias,
W. Young, R.P. Hart and R. J. Perez-Polo. DNA microarray analysis of
the contused spinal cord: The effect of NMDA receptor inhibition. JNR
68:406-423, 2002.
- Cole, K.K. and J.R. Perez-Polo. Poly (ADP-Ribose) Polymerase
Inhibition Prevents both Apoptotic-like Delayed Neuronal Death and
Necrosis after H2O2 Injury. J. Neurochemistry, 82:19-29, 2002.
- Lange-Dohna, C, Zeitschel U., Gaunitz F., Perez-Polo
R., Bigl V & Rossner S. Cloning and expression of the rat BACE1 promoter.
J. Neurosci. Res. 73(1):73-80, 2003.
|